Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza. | Open Forum Infect Dis | 2023 | 36949873 | PubTator, text mining | PubMed |
| Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma. | BMC Cancer | 2023 | 36949462 | PubTator, text mining | PubMed |
| Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression. | Mol Ther Oncolytics | 2023 | 36938543 | PubTator, text mining | PubMed |
| A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma. | Front Immunol | 2023 | 36936935 | PubTator, text mining | PubMed |
| Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. | BMC Bioinformatics | 2023 | 36935487 | PubTator, text mining | PubMed |
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments. | J Crohns Colitis | 2023 | 36934327 | PubTator, text mining | PubMed |
| Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assays. | Sci Rep | 2023 | 36932139 | PubTator, text mining | PubMed |
| Recent advances in the role of endogenous hydrogen sulphide in cancer cells. | Cell Prolif | 2023 | 36929586 | PubTator, text mining | PubMed |
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial. | EBioMedicine | 2023 | 36921563 | PubTator, text mining | PubMed |
| High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome. | J Endocrinol Invest | 2023 | 36917420 | PubTator, text mining | PubMed |
| Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer. | Gland Surg | 2023 | 36915817 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| NFκB signaling in T cell memory. | Front Immunol | 2023 | 36911729 | PubTator, text mining | PubMed |
| PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. | Cells | 2023 | 36899918 | PubTator, text mining | PubMed |
| Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis. | Front Endocrinol (Lausanne) | 2023 | 36896172 | PubTator, text mining | PubMed |
| CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients. | J Transl Med | 2023 | 36895015 | PubTator, text mining | PubMed |
| Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. | EBioMedicine | 2023 | 36893588 | PubTator, text mining | PubMed |
| Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosis. | Front Immunol | 2023 | 36875109 | PubTator, text mining | PubMed |
| Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. | Sci Rep | 2023 | 36871072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=20